Mir-31-3p as a predictive biomarker of cetuximab effects in a post hoc analysis of new EPOC phase III trial.
Pierre Laurent-Puig
Consultant or Advisory Role - IntegraGen; Merck Serono; Sanofi
John A. Bridgewater
Consultant or Advisory Role - AstraZeneca; Merck; Roche; Sanofi
John Neil Primrose
Consultant or Advisory Role - Bayer; Merck; Roche; Sanofi
Sian Alexandra Pugh
No relevant relationships to disclose
Gareth Thomas
No relevant relationships to disclose
Karwan Moutasim
No relevant relationships to disclose
Francis Rousseau
Employment or Leadership Position - IntegraGen
Karine Fontaine
Employment or Leadership Position - IntegraGen
Celine Vazart
Employment or Leadership Position - IntegraGen
Virginie Decaulne
Employment or Leadership Position - IntegraGen
Anne Leclair
Employment or Leadership Position - IntegraGen
Berengere Genin
Employment or Leadership Position - IntegraGen
Sandrine Imbeaud
Consultant or Advisory Role - IntegraGen
Francois Liebaert
Employment or Leadership Position - IntegraGen
Raphaƫle ThiƩbaut
Employment or Leadership Position - IntegraGen